Malignant mesothelioma masquerading as a multinodular bronchioloalveolar cell adenocarcinoma with widespread pulmonary nodules

International Journal of Surgical Pathology

Volumn 14, Issue 3, 2006, Pages 229-233

  Felner, Kevin J ^b   Wieczorek, Rosemary ^a   Kline, Marilyn ^b   Smith, Robert L ^b   Sidhu, Gurdip S ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Bronchioloalveolar carcinoma; Mesothelioma; Multinodular

Indexed keywords

ALCIAN BLUE; CALRETININ; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; GLYCOSAMINOGLYCAN; HYALURONIC ACID; HYALURONIDASE; MUCIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR PROTEIN; WT1 PROTEIN;

AGED; ARTICLE; CANCER CELL; CASE REPORT; CELL GROWTH; DIFFERENTIAL DIAGNOSIS; ENZYME DEGRADATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG BIOPSY; LUNG NODULE; MALE; MALIGNANT MESOTHELIOMA; PERIODIC ACID SCHIFF STAIN; PLEURA BIOPSY; PLEURA EFFUSION; PRIORITY JOURNAL; STAINING; THORACOSCOPY; TUMOR CELL; ULTRASTRUCTURE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; COIN LESION, PULMONARY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYALURONIC ACID; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVILLI; MUCINS; PLEURAL NEOPLASMS; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 33748987942     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896906290363     Document Type: Article

References (15)

1. Sidhu GS, Wieczorek R, Cassai ND, Zhu C-C. The concept of bronchioloalveolar carcinoma: redefinition, a critique of the 1990 WHO classification, and an ultrastructural analysis of 155 cases. Int J Surg Pathol. 2003;11:89-99.
2. Rosenblatt MB, Lisa JR, Collier F. Primary and metastatic bronchiolo-alveolar carcinoma. Dis Chest. 1967;52:147-152.
3. Nind NR Attanoos RL Gibbs AR. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. Histopathology. 2003;42:150-155.
4. Hammar SP, Bockus DE, Remington FL, Rohrbach KA. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing adenocarcinomas. Ultrastruct Pathol. 1996;20:293-325.
5. Lin Z, Dobra K, Hauzenberger D, Klominek J. Expression of hyaluronan synthase and hyaluronan in malignant mesothelioma cells. Anticancer Res. 2004;24:599-603.
6. Nakano T, Fujii J, Tamura S, Hada T, Higashino K. Glycosaminoglycans in malignant pleural mesothelioma. Cancer. 1986;57:106-110.
7. Pettersson T, Froseth B, Riske H, Klockers M. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest. 1988;94:1037-1039.
8. Truedsson E. A case of mesothelioma of the pleura and peritoneum producing hyaluronic acid. Acta Soc Med Ups. 1951;56:39-45.
9. Battifora H. The pleura. In: Sternberg SS, ed. Diagnostic Surgical Pathology, 3rd ed. New York, NY: Raven Press; 1999:1117-1143.
10. Ohishi N, Teruaki O, Fukuhara T, Yotsumoto H, Yazaki Y. Extensive pulmonary metastases in malignant pleural mesothelioma. Chest. 1996;110:296-298.
11. Uri AJ, Schulman ES, Steiner RM, Scott RD, Rose LI. Diffuse contralateral pulmonary metastases in malignant mesothelioma. Chest. 1988;93:433-434.
12. Huncharek M. Miliary mesothelioma. Chest. 1994;106:605-606.
13. Livsay CA, Tishko DJ, Maygarden SJ. Miliary pulmonary metastases from a clinically occult pleural mesothelioma. Ann Diagn Pathol. 2003;7:249-253.
14. Musk AW, Shilkin DJ, Whitaker D. Miliary spread of malignant pleural mesothelioma without a clinically identifiable pleural tumor. Aust NZ J Med. 1991;21:466-462.
15. Oury TD, Hammar SP Roggli VI. Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol. 1998;29:1382-1392.